BUZZ-<a href="https://laohu8.com/S/ANGO">Angiodynamics</a> up after annual sales forecast raise** Shares of medical device maker Angiodynamics ANGO.O rise about 8% to $14.28 in premarket trading
** Co lifts FY2026 net sales forecast in the range of $312 million to $314 million from prior expectations of $308 million to $313 million
** Also raises annual adjusted EBITDA between $8 million to $10 million, compared with a previous range of $6 million to $10 million
** Co reports Q2 net loss of $6.4 million vs net loss of $10.7 million last year
** Jim Clemmer will retire as president and CEO during FY2027 once the company appoints a successor
** ANGO stock up ~40% in 2025
(Reporting by Sanskriti Shekhar in Bengaluru)
((Sanskriti.Shekhar@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments